FDA Inspection 1249658 — Anhye Kim, M.D., Ph.D
The FDA completed an inspection of Anhye Kim, M.D., Ph.D on August 16, 2024 in Seongnam. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 16, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seongnam (Korea (the Republic of))
Additional Details
Clinical BA/BE